Beginning Cash: The amount of cash reported by the company on its previous statement.
Palvella Therapeutics, Inc. (PVLA) had Beginning Cash of $83.60M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-11.35M |
|
-- |
|
-- |
|
$10.18M |
|
$-10.18M |
|
$-1.17M |
|
$-11.35M |
|
$-11.35M |
|
$-11.35M |
|
$-11.35M |
|
$-11.35M |
|
$-11.35M |
|
$-10.18M |
|
$-10.18M |
|
11.06M |
|
11.06M |
|
$-1.03 |
|
$-1.03 |
|
| Balance Sheet Financials | |
$66.94M |
|
-- |
|
-- |
|
$66.94M |
|
$10.31M |
|
-- |
|
$17.94M |
|
$28.25M |
|
$38.68M |
|
$38.68M |
|
$38.68M |
|
11.09M |
|
| Cash Flow Statement Financials | |
$-20.08M |
|
-- |
|
$-0.61M |
|
|
Beginning Cash |
$83.60M |
$63.57M |
|
$-20.04M |
|
$4.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.49 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-20.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-29.33% |
|
-29.33% |
|
-16.95% |
|
-29.33% |
|
$3.49 |
|
$-1.81 |
|
$-1.81 |
|